Amgen Says Recent Sensipar Study Failed to Meet Primary Endpoint

Date : 06/08/2012 @ 10:24AM
Source : Dow Jones News
Stock : Amgen Inc. (MM) (AMGN)
Quote : 185.76  -0.88 (-0.47%) @ 8:00PM

Amgen Says Recent Sensipar Study Failed to Meet Primary Endpoint

Amgen Inc. (MM) (NASDAQ:AMGN)
Historical Stock Chart

5 Years : From Sep 2012 to Sep 2017

Click Here for more Amgen Inc. (MM) Charts.
   By Mia Lamar 
 

Amgen Inc. (AMGN) said Friday that a study evaluating its Sensipar drug for effectiveness in reducing the risk of mortality and cardiovascular events in patients suffering from chronic kidney disease failed to meet its primary endpoint.

Sensipar--which is marketed as Mimpara in Europe--was first approved in 2004 to treat thyroid problems in patients with kidney disease and cancer. The company recorded $808 million in global sales of the drug last year.

Amgen said Friday it undertook the Phase 3 trial of Sensipar to discover whether the drug could positively impact the high rates of mortality and incidences like heart failure experienced by patients with chronic kidney disease that are receiving dialysis.

Results, however, were not statistically significant, Amgen said.

The company noted analyses from the study are ongoing and will be submitted for presentation at a major medical meeting later this year.

Amgen, the biggest stand-alone biotechnology company, has been pursuing deals to bolster its research-and-development pipeline as sales growth slows for older drugs.

Shares were recently off 26 cents to $68.84.

Write to Mia Lamar at mia.lamar@dowjones.com

Latest AMGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.